The first vaccinations are due to begin in the US, with the government extending its agreement with Moderna to bolster its vaccines supplies.
The first immunizations against COVID-19 in the United States are to begin on 14 December, following the historic first emergency use authorization (EUA) of a vaccine, Pfizer/BioNTech’s BNT162b2.
The messenger RNA vaccine was granted the emergency clearance by the US Food and Drug Administration late on 11 December,...
Deal Snapshot: Jazz, which sells Epidiolex for rare seizure disorders, will pay $42.5m up front to take over development of Saniona’s preclinical Kv7.2/Kv7.3 activator SAN2355 for epilepsy.
Four days after Wegovy became the second approved MASH therapy in the US, Rezdiffra gets the first European approval. Plans are for an initial launch in Germany.
All eyes on chronic urticaria after eosinophilic esophagitis disappointment.
